Overview

Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is to determine whether vancomycin with cefazoline is superior to vancomycin with placebo in preventing gastrostomy-related wound infection in carriers of methicillin-resistant staphylococcus aureus (MRSA).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Geneva
Treatments:
Vancomycin
Criteria
Inclusion Criteria:

- PEG insertion in a patient with a swab positive for MRSA during the 4 weeks preceding
PEG insertion

Exclusion Criteria:

- Age < 18 years

- No informed consent obtained either from the patient or from his legal representative

- Contraindication to the administration of cefazolin or of vancomycin

- Systemic administration of antibiotics effective against MRSA during the week prior to
the procedure

- Technique of PEG insertion different from the standard pull technique proposed by the
physician in charge and the gastroenterologist

- Patients requiring antibiotic prophylaxis of endocarditis